Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-04-11

Clinical Trial Update: A Data Collection Study for the Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment

View source ↗

Summary

The clinical trial evaluating a novel infrared breast imaging system for breast cancer risk assessment has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Real Imaging Ltd. | Conditions: Breast Cancer | Status: WITHDRAWN